Page 100 - MI-1-1

Microbes & Immunity Dynamics between phage, bacteria, and mammalian cells

the adhesion of Acinetobacter baumannii to host cells. PLoS doi: 10.1046/j.1365-3083.2002.01137.x
One. 2012;7(4):e33073.
46. Liu X, Yin S, Chen Y, et al. LPS-induced proinflammatory
doi: 10.1371/journal.pone.0033073 cytokine expression in human airway epithelial cells and
42. McCallin S, Oechslin F. Bacterial resistance to phage and its macrophages via NF-κB, STAT3 or AP-1 activation. Mol
impact on clinical therapy. In: Górski A, Międzybrodzki R, Med Rep. 2018;17(4):5484-5491.
Borysowski J, editors. Phage Therapy: A Practical Approach. doi: 10.3892/mmr.2018.8542
Berlin: Springer International Publishing; 2019. p. 59-88.
47. Clark RT, Hope A, Lopez-Fraga M, Schiller N, Lo DD.
43. Gordillo Altamirano F, Forsyth JH, Patwa R, et al. Bacteriophage- Bacterial particle endocytosis by epithelial cells is selective
resistant Acinetobacter baumannii are resensitized to and enhanced by tumor necrosis factor receptor ligands.
antimicrobials. Nat Microbiol. 2021;6(2):157-161. Clin Vaccine Immunol. 2009;16(3):397-407.
doi: 10.1038/s41564-020-00830-7 doi: 10.1128/cvi.00210-08
44. Fahey JV, Schaefer TM, Channon JY, Wira CR. Secretion of 48. Archana A, Patel PS, Kumar R, Nath G. Neutralizing antibody
cytokines and chemokines by polarized human epithelial response against subcutaneously injected bacteriophages in
cells from the female reproductive tract. Hum Reprod. rabbit model. Virusdisease. 2021;32(1):38-45.
2005;20(6):1439-1446.
doi: 10.1007/s13337-021-00673-8
doi: 10.1093/humrep/deh806
49. Divya Ganeshan S, Hosseinidoust Z. Phage therapy with
45. Schulz C, Farkas L, Wolf K, Kratzel K, Eissner G, Pfeifer M.
Differences in LPS-induced activation of bronchial epithelial a focus on the human microbiota. Antibiotics (Basel).
cells (BEAS-2B) and type II-like pneumocytes (A-549). 2019;8(3):131.
Scand J Immunol. 2002;56(3):294-302. doi: 10.3390/antibiotics8030131

Volume 1 Issue 1 (2024) 94 doi: 10.36922/mi.3141